Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease Usama Abdel Azim Sharaf El Din; Mona Mansour Salem; Dina Ossama Abdulazim;

Mineralcorticoid receptor blockers in chronic kidney disease Sara Erraez; Manuel López-Mesa; Pablo Gómez-Fernández;

Cost-effectiveness of sodium zirconium cyclosilicate for the treatment of hyperkalemia in patients with chronic kidney disease or heart failure in Spain Roberto Alcázar-Arroyo; María G Crespo-Leiro; Jordi Bover; Juan Oliva; Miren Sequera-Mutiozabal; Simona Gradari; Anisia Martínez-López; Blanca López-Chicheri; Neus Vidal-Vilar; Susana Aceituno; Marta Cobo;